Paclitaxel chemotherapy frequently induces neuropathic pain during and often persisting after therapy. The mechanisms responsible for this pain are unknown. Using a rat model of paclitaxel-induced painful peripheral neuropathy, we have performed studies to search for peripheral nerve pathology. Paclitaxel-induced mechano-allodynia and mechano-hyperalgesia were evident after a short delay, peaked at day 27 and finally resolved on day 155. Paclitaxel-and vehicle-treated rats were perfused on days 7, 27 and 160. Portions of saphenous nerves were processed for electron microscopy. There was no evidence of paclitaxel-induced degeneration or regeneration as myelin structure was normal and the number/density of myelinated axons and C-fibres was unaltered by paclitaxel treatment at any time point. In addition, the prevalence of ATF3-positive dorsal root ganglia cells was normal in paclitaxel-treated animals. With one exception, at day 160 in myelinated axons, total microtubule densities were also unaffected by paclitaxel both in C-fibres and myelinated axons. C-fibres were significantly swollen following paclitaxel at days 7 and 27 compared to vehicle.The most striking finding was significant increases in the prevalence of atypical (swollen and vacuolated) mitochondria in both C-fibres (1.6-to 2.3-fold) and myelinated axons (2.4-to 2.6-fold) of paclitaxel-treated nerves at days 7 and 27. Comparable to the pain behaviour, these mitochondrial changes had resolved by day 160. Our data do not support a causal role for axonal degeneration or dysfunction of axonal microtubules in paclitaxel-induced pain. Instead, our data suggest that a paclitaxel-induced abnormality in axonal mitochondria of sensory nerves contributes to paclitaxel-induced pain. Ó
Introduction
Paclitaxel (Taxol Ò ) is a widely used chemotherapeutic agent derived from Pacific yew tree bark (Wani et al., 1971) . It is indicated for the treatment of ovarian, breast and non-small cell lung carcinomas and Kaposi's sarcoma. Paclitaxel binds to b-tubulin of microtubules, which form the mitotic spindle (Nogales et al., 1995) , thereby stabilizing microtubules and enhancing microtubule polymerization (Kumar, 1981) , a mechanism that was thought to underlie paclitaxel's anti-tumour effect. However, it appears that the suppression of spindle-microtubule dynamics plays a greater role in paclitaxel's chemotherapeutic properties (Yvon et al., 1999) . Such suppression halts mitosis at the metaphase-anaphase transition, inducing apoptosis (Jordan et al., 1996; Kelling et al., 2003) .
Peripheral neurotoxicity is a serious dose-limiting side effect of paclitaxel therapy. It evokes an array of symptoms; numbness and tingling, mechanical allodynia, cold allodynia and on-going burning pain. Patients 
